Page 133 - 《中国药房》2024年15期
P. 133

中药活性成分及复方调控 JAK/STAT 信号通路改善肝纤维化的

          研究进展
                        Δ

                 1*
                           2 #
                                             2
                                                                      1
                                    2
                                                     2
          邓斯铭 ,刘礼剑 ,黎丽群 ,杨成宁 ,韦金秀 ,李建锋 ,黄明珠 ,谢丽丽(1.广西中医药大学研究生学院,
                                                              2
                                                                               1
          南宁 530001;2.广西中医药大学第一附属医院脾胃病科,南宁 530001)
          中图分类号  R965;R285.5      文献标志码  A      文章编号  1001-0408(2024)15-1923-05
          DOI  10.6039/j.issn.1001-0408.2024.15.21
          摘  要  肝纤维化是各种慢性肝损伤的病理过程,若不及时治疗,最终可能导致肝硬化或肝癌。Janus激酶/信号转导及转录激活
          蛋白(JAK/STAT)信号通路与肝纤维化的发生发展密切相关。本文基于JAK/STAT信号通路总结了中药活性成分及复方改善肝纤
          维化的研究进展,发现活血化瘀类(如鬼箭羽醇、紫杉醇等成分及二十五味松石丸、肝复康等复方)、清热解毒类(如桦木酸、杠板归
          总黄酮等成分及片仔癀、克癀胶囊等复方)、疏肝行气类(如秦皮素、葫芦素B等成分及柴胡疏肝散、小柴胡汤等复方)中药活性成
          分和复方均可通过抑制JAK/STAT信号通路活性,降低炎症反应,抑制肝星状细胞增殖等,发挥改善肝纤维化的作用。
          关键词  肝纤维化;JAK/STAT信号通路;中药;活性成分;复方

          Research  progress  of  active  components  and  compounds  of  traditional  Chinese  medicine  improving  liver
          fibrosis by regulating JAK/STAT signaling pathway
          DENG Siming ,LIU Lijian ,LI Liqun ,YANG Chengning ,WEI Jinxiu ,LI Jianfeng ,HUANG Mingzhu ,XIE
                                                                                     2
                                            2
                                                                                                       1
                      1
                                                             2
                                                                         2
                                  2
          Lili(1. Graduate School, Guangxi University of Chinese Medicine, Nanning 530001, China;2. Dept. of Spleen
             1
          and  Stomach  Diseases,  the  First  Affiliated  Hospital  of  Guangxi  University  of  Chinese  Medicine,  Nanning
          530001, China)
          ABSTRACT   Hepatic  fibrosis  is  a  pathological  process  of  chronic  liver  injury.  Without  timely  intervention  and  treatment,  liver
          fibrosis  may  eventually  lead  to  liver  cirrhosis  and  cancer.  Janus  kinase (JAK)/signal  transducer  and  activator  of  transcription
         (STAT)  signaling  pathway  is  closely  associated  with  the  occurrence  and  development  of  liver  fibrosis.  Based  on  this,  this  paper
          summarized and analyzed the mechanism and effects of active ingredients and compounds of traditional Chinese medicine improving
          liver  fibrosis  based  on  JAK/STAT  signaling  pathway.  It  is  found  that  the  active  ingredients  and  compounds  of  traditional  Chinese
          medicine  that  promote  blood  circulation  and  remove  blood  stasis (ingredients  such  as  ethanol  extract  of  Euonymus  alatus  and
          paclitaxel, as well as compounds such as Ershiwuwei songshi pill and Ganfukang), clear away heat and toxic material (ingredients
          such  as  betulinic  acid,  total  flavonoids  from  Persicaria  perfoliata,  as  well  as  compounds  such  as  Pianzaihuang  and  Kehuang
          capsules),  and  sooth  the  liver  and  promote  qi  circulation (ingredients  such  as  fraxetin  and  cucurbitacin  B,  as  well  as  compounds
          such  as  Chaihu  shugan  powder  and  Xiaochaihu  decoction)  can  all  relieve  liver  fibrosis  by  inhibiting  the  activity  of  the  JAK/STAT
          signaling pathway, reducing inflammatory reactions, and inhibiting the proliferation of hepatic stellate cells.
          KEYWORDS    liver fibrosis; JAK/STAT signaling pathway; traditional Chinese medicine; active ingredients; compounds


              肝纤维化指各种致病因子导致慢性肝损伤时机体                          疗肝纤维化的方法具有重要意义。
          发生的一种伤口愈合反应,以过多胶原积累为主要特                                中医尚无“肝纤维化”的病名记载,但根据肝纤维化
                                                                                                           [5]
          征 。肝纤维化为一种慢性、可逆性的病理现象,若不及                          的临床特征,可将其归为“积聚”“癥瘕”“臌胀”等范畴 。
            [1]
          时治疗则可能会发展为不可逆的肝癌或肝硬化                    [2―3] 。西   其病机为外伤湿寒、内伤饮食、情志不节、气滞血瘀等,
                                                             可导致脾胃受损、水湿不化、精血不生、脏腑功能失常、
          医治疗肝纤维化以抗病毒及对症治疗为主,但其存在治
                                                             气虚血滞成瘀,久之癥瘕结块,最终形成肝纤维化,这与
                                       [4]
          疗药物种类少、毒副作用多等缺点 。因此,探索新的治
                                                             西医病理中细胞外基质(extracellular matrix,ECM)过度
             Δ 基金项目 广西自然科学基金项目(No.2023GXNSFAA026049);        沉积形成肝纤维化的机制不谋而合 。Janus 激酶/信号
                                                                                            [6]
          广 西 医 疗 卫 生 重 点 学 科 和 重 点 培 育 学 科 项 目(No. 桂 卫 科 教 发
                                                             转导及转录激活蛋白(Janus kinase/signal transducer and
         〔2023〕1号)                                           activator of transcription,JAK/STAT)信号通路可参与肝
             *第一作者 硕士研究生。研究方向:中医药防治脾胃疾病的应
                                                             免疫与肝再生,直接促进肝星状细胞(hepatic stellate
          用。E-mail:2055817220@qq.com
             # 通信作者 主任医师,硕士生导师。研究方向:中医药防治脾胃                  cells,HSCs)生长和分裂,使ECM沉积加快,从而促进肝
                                                                           [7]
          疾病的应用。E-mail:liulijian0_1@163.com                  纤维化病理进程 。因此,抑制该信号通路活性,可有效
          中国药房  2024年第35卷第15期                                              China Pharmacy  2024 Vol. 35  No. 15    · 1923 ·
   128   129   130   131   132   133   134   135   136   137   138